7 ms·
FDA considers first CRISPR gene editing treatment that may cure sickle cell
- sohkamyung 3y agoSimilar treatment already approved by the UK [1] [1] https://www.nature.com/articles/d41586-023-03590-6 https://www.nature.com/articles/d41586-023-03590-6
- getoffmycase 3y agoSmall correction: this is the same drug as the one already approved by the UK.
- incompatible 3y agoIt's fairly expensive: "estimates suggest that it could cost roughly US$2 million per patient, in line with the pricing of other gene therapies." I assume it's a long and labour-intensive process?
- _qua 3y agoGiven the resources consumed by sickle cell patients, who often require multiple lengthy hospitalizations I bet it would be close to breakeven even at this price
- nemonemo 3y agoWould insurances cover it on the basis like that? I wonder if there is any similar medicine that is covered for a similar total treatment reason.
- genericresponse 3y agoThe recent curative hepatitis treatments have paved the way for this. There are a variety of different approaches including statewide cost sharing funds that pool the cost across all the insurers in the state.
- nxobject 3y agoIIRC, single-payer health care systems like the NHS do functionally the exact same thing, which allows them to negotiate significant discounts. I remember reading about a gene therapy for a type of leukodystropphy that was in the millions of dollars, but got negotiated down. [1] https://www.england.nhs.uk/2023/02/first-baby-receives-life-saving-gene-therapy-on-nhs/#:~:text=The%20revolutionary%20gene%20therapy%2C%20known,most%20expensive%20drug%20licensed%20in https://www.england.nhs.uk/2023/02/first-baby-receives-life-...
- saulrh 3y agoThe cynic in me says that it was probably priced to cost exactly the same as the expected lifetime expense of treating of the disease.
- vedtopkar 3y agoIn fact this is exactly how they set the price for these curative treatments. Gargantuan sums but hypothetically on average cheaper than the overall lifetime costs of living with the disease. Lots of recent debates on this in the world of Hepatitis C.
- fsckboy 3y agopricing like that only lasts as long as the patent, the argument being that without the opportunity for that pricing, the research for the drug would not be worthwhile in the first place. I'm not arguing this is true, but I wouldn't accept a counterargument based on "but it's people, it's people, think of the children"
- WesolyKubeczek 3y agoIt’s probably one of the precious few arguments where “think of the children” is actually valid.
- thaumasiotes 3y agoHere are some other counterarguments: - Most formal drug research, today, is already not worthwhile. The norm is that you spend several billion dollars and recover nothing. - Most achievements that were worthwhile in retrospect were not worthwhile prospectively. Therefore it is not obvious that things need to be worthwhile prospectively in order to be done. Going into a career as a rock star is, objectively, stupid. But we have a huge supply of wannabe rock stars anyway.
- flukus 3y agoA more charitable interpretation might be that getting under the cut off is why it's one of the first treatments available. More treatments will become available as the overall costs start beating out the costs of living with $disease.
- dekhn 3y agoyes, they extract the cells from the patient, then crispr them in a lab with a complex protocol, and then inject them back into the patient. But it's a cure, not a treatment.
- huytersd 3y agoIs it just the once. Or do you have to have repeated infusions?
- ajross 3y agoAs with everything though, prices for experimental procedures and devices are vastly higher than the asymptotic cost of production. There's nothing about a CRISPR process that cannot in principle be automated, it's just that right now it involves an army of lab techs with pipettes.
- deleted 3y ago[deleted]
- deleted 3y ago[deleted]
- diyseguy 3y agoWhy does it have to be so expensive? Just because they "can"?
- parl_match 3y agoBecause right now, it's a very bespoke process. Very low supply, with a lot demand. As more people become proficient at this treatment, the cost will come down. But to truly get it down to reasonable amount will require automation, and we're a long way off from automating crispr.
- tjohns 3y agoThat's a complicated topic, but the short version is cost of this treatment needs to cover the R&D costs to develop it, plus the costs for all the other failed experiments that didn't work out. Plus gene therapy is in its infancy, so everything here is going to be novel and expensive. Novel treatments generally have a limited audience with even fewer practitioners, so you can't spread the R&D costs across many patients. Prices will go down with time as patents expire and competitors emerge and this line of treatment (perhaps) becomes mainline, but that's on a ~20 year timeframe.
- dekhn 3y agoWe don't have a lot of experience with taking cells out of the human body, processing them, and then putting them back in. A significant amount of the cost, above and beyond the R&D required to develop the treatment and the cost of actually performing the cure, comes from extreme quality control measures that reduce the chances of infection and other problems. Also, you have to basically run a full, certified lab and house it with people qualified to perform the cure. Everything about this is bespoke (each treatment is based on the individual cells of a patient) and artisanal (the process requires a highly skilled individual to complete), and run by a guild (only so many people are allowed to run gene therapy trials). On the other hand, since this is a cure, and probably reduces long-term medical care costs, it could very well actually be "cheaper" in the long run, which incentivizes the government to treat as many people as possible.
- GeekyBear 3y agoThe Human Genome Project to read a full copy of the base pair sequence in one human started out with about 3 Billion dollars in initial funding, and it took a couple of decades to get complete coverage. However, the technology, techniques and equipment developed to automate the process have massively cut costs and increased speed over that time. > A new speed record in DNA sequencing may soon help families more quickly find answers to difficult and life-altering questions. In just 7 hours, 18 minutes, a team of researchers at Stanford Medicine went from collecting a blood sample to offering a disease diagnosis. This unprecedented turnaround time is the result of ultra-rapid DNA sequencing technology paired with massive cloud storage and computing. https://www.asbmb.org/asbmb-today/science/022722/record-breaking-rapid-dna-sequencing https://www.asbmb.org/asbmb-today/science/022722/record-brea... You have to crawl before you can run.
- Full_Clark 3y agoGene therapies are being priced according to the annual costs of treatments they replace, not the cost of producing the gene therapy product or the value of the cure to the patients. For example, Hemgenix is a gene therapy for hemophilia. It is a single-dose product priced at $3.5 million [1]. It's not CRISPR-based, so it's not an apples-to-apples comparison with the sickle-cell treatment discussed in the article. But I know from officials at the World Federation of Hemophilia that the direct costs of production and administration for Hemgenix are around $50,000. That's two orders of magnitude less than the list price. The $3.5 million figure was likely arrived at because the existing products for hemophilia cost north of 350k annually, and Hemgenix is estimated to replace them for 8+ years. [1]https://www.scientificamerican.com/article/3-5-million-hemophilia-gene-therapy-is-worlds-most-expensive-drug/ https://www.scientificamerican.com/article/3-5-million-hemop...
- mschuster91 3y ago> But I know from officials at the World Federation of Hemophilia that the direct costs of production and administration for Hemgenix are around $50,000. That's two orders of magnitude less than the list price. That doesn't account for the R&D effort which has to be recouped during the runtime of the patent. Depending on whom you ask, that can reach into billions of dollars [1], and there's just about 200k people diagnosed with some form of hemophilia of which only a fraction has the funds or the insurance to obtain that kind of treatment in the first place (both the current and the new one), so these few patients have to account for the R&D cost of the medication, the R&D cost of failed candidate substances, the R&D for ongoing other medication and profits. For "orphan diseases", these economies are a serious problem. Pharmaceutical development is incredibly expensive; to make it worse a lot of governments have cut back drastically on fundamental R&D grants for universities and so private companies with their profit interests stepped in. [1] https://msf-access.medium.com/how-much-do-clinical-trials-cost-the-answer-is-overdue-25fa64b3cd27 https://msf-access.medium.com/how-much-do-clinical-trials-co... [2] https://www.pfizer.com/disease-and-conditions/hemophilia https://www.pfizer.com/disease-and-conditions/hemophilia
- Full_Clark 3y ago
- foxyv 3y agoThis is absolutely awesome. I look forward to finding out if this has an effect on the germ line as well. Imagine, ending genetic illnesses like these for the rest of human history. I look forward to forgetting these diseases even exist, except in the archives of medical history.
- 7thaccount 3y agoI watched a special on this and all interviewed scientists were drastically against any germ line edits (as in something that would then be passed to offspring) as we simply don't understand things well enough yet. Some groups will eventually do this in a less regulated nation, but for now we have to be very careful.
- couchand 3y ago"Eventually" already passsed five years ago. https://en.m.wikipedia.org/wiki/He_Jiankui_affair https://en.m.wikipedia.org/wiki/He_Jiankui_affair
- 7thaccount 3y agoI remembered that, but since it was an isolated incident chose to ignore it. I meant at some point China or some other country is going to just give a blanket approval or just not enforce any restrictions and then the game is on.
- foxyv 3y agoI imagine this wouldn't be a huge issue with women since they don't produce eggs after birth, but men continue to produce gametes for life. Is there a way to prevent the introduction of the CRISPR edits to spermatocytes? Or do you just have to bank sperm and sterilize as a condition for the treatment?
- ch4s3 3y agoThey’re targeting specialized cells that make blood cells outside of the body. Once they’re reimplemented they don’t move around.
- folli 3y agoObligatory reminder of the "fun" fact that sickle cell disease leads to a sort of partial malaria resistance, which explains its perseverance in the human gene pool. https://doi.org/10.1073/pnas.1804388115 https://doi.org/10.1073/pnas.1804388115
- deleted 3y ago[deleted]
- galangalalgol 3y agoThey are trialing a malaria vaccine now too. What if at birth we all got that malaria vaccine and a crispr that made everyone a carrier of sickle cell, but not germ line. That seems like we could wipe out both sickle cell and malaria.
- bobthepanda 3y agohere's hoping. malaria is an interesting one where multiple antimalarials have been developed and then lost efficacy.
- pkaye 3y agoType O blood can also protect against severe malaria where the uninfected blood cells stick around one that is infected.
- pard68 3y agoThat's "sickle cell trait" which is when you are only carrier but do not have the disease. With the disease, malaria is even more deadly.
- m3kw9 3y agoIf it benefits or isn’t detrimental to shareholders..
- 6177c40f 3y agoGiven that Sickle Cell Disease only affects ~20 million people in the entire world [1], and beta-thalassemia affects even fewer (maybe ~200,000 people) [2], and that this treatment currently costs millions of dollars per person, I think shareholders will be just fine. [1] https://www.nhlbi.nih.gov/health/sickle-cell-disease https://www.nhlbi.nih.gov/health/sickle-cell-disease [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893117/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893117/
- trallnag 3y agoDoesn't it only affect Africans?
- defrost 3y agoThe trait is present in up to 3% of births in some parts of sub-Saharan Africa. In America * About 1 in 13 black babies are born with sickle cell trait. * About 1 in every 365 black babies are born with sickle cell disease. * People who come from Hispanic, Southern European, Middle Eastern, or Asian Indian backgrounds can also have sickle cell disease. * Of the 74 817 hospitalized for sickle cell disease (2016 to 2018), 69 889 (93.4%) were Blacks, 3603 (4.8%) were Hispanics, and 1325 (1.8%) were Whites.
- HorizonXP 3y agoMy goddaughter (and her older brother) have sickle cell. Her parents have been hoping and praying for some development in this field for years now. It’ll still be a while before they can obtain this treatment in Canada, but suffice it to say, it’s likely to be cured in their lifetime. It is debilitating and affects a lot of their everyday life. I’m really happy this is progressing.
- fnordpiglet 3y agoFor what it’s worth my grandfather researched sickle cell and found that l-citrulline supplementation greatly improves quality of life for people with sickle cell. Unfortunately sports supplementation and erectile dysfunction treatment was the more lucrative of his patents and he died before he could finish FDA approval work for treatment of sickle cell anemia (not a cure). As citrulline isn’t expensive no one was willing to pick up his research. He provided citrulline to his patients throughout his life as their quality of life improved dramatically as to be entirely normal. I don’t know that anyone kept track of them after his death, but his research into citrulline for other purposes such as erectile and exercise performance ensured that it’s widely available now. https://thescholarship.ecu.edu/handle/10342/3137 https://thescholarship.ecu.edu/handle/10342/3137 You can purchase it from many places but this manufacturer has a good reputation: BULKSUPPLEMENTS.COM L-Citrulline Malate 2:1 Powder - L Citrulline Malate Supplement, Citrulline Malate Powder - Unflavored & Gluten Free - 3g per Servings, 333 Servings, 1kg (2.2 lbs) https://a.co/d/fzNovRX https://a.co/d/fzNovRX Citrulline is extremely safe in any quantity. Any excess is urinated out.
- WhitneyLand 3y agoI think people are downvoting your answer incorrectly. Best I can tell that’s because you used the word SUPPLEMENTS in all caps which is reminiscent of spam email. However, while I can’t validate anything about your grandfather what you’re saying seems plausible and some papers have talked about it. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2594068 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2594068
- 3y ago
- myko 3y agoBetween this and mRNA vaccine technology the future of medicine is looking bright
- digdigdag 3y agoAnd expensive...and out of reach of most of the people who need it.
- ehsankia 3y agomRNA isn't necessarily. The custom made cancer ones are, but that's different.
- Turing_Machine 3y agoThe government literally gave away mRNA vaccines.
- devmor 3y agomRNA editing is actually disturbingly cheap and easy to do (relatively speaking). With the right preparation and equipment, it could be a highschool science class project.
- huytersd 3y agoNonsense. India started pumping out covid mRNA drugs for dirt cheap in just a few months.
- ehsankia 3y agoAnd AlphaFold! Which is a game changer for drug development.
- diego_sandoval 3y agoAnd Brain-Computer Interfaces.
- deleted 3y ago[deleted]
- tetramer 3y agoCRISPR is definitely an awesome technology, and I'm glad that after many decades of research, we're finally getting approved treatments as a result. That being said, I do want to clarify that this isn't a "cure" for sickle cell disease. It is not editing the gene causing sickle cell itself, but rather allowing for increasing production of HbF (fetal hemoglobin) by knocking down a suppressor. Hydroxyurea, a current standard of care option in sickle cell disease, also increases HbF production but response can be variable among patients (but when it works, absolutely improves quality of life!) In addition, I think we always need to keep in mind potential toxicities and hopefully, we learn more about this when the publication actually comes out. It's important to note that giving this therapy requires giving high dose chemotherapy beforehand, and I'd also be interested in knowing how long this therapy actually lasts as I do expect the product may wane with time. But still, so excited to see CRISPR technology coming to the public and the potential for this technology in many different disease states!
- WhitneyLand 3y agoSays who? I honestly don’t know, but qualifying as a “cure” doesn’t require fixing the original thing that was broken. Whether something is classified as a cure or treatment just depends on the extent and permanence of its effectiveness. Is that not what’s happening here?
- ChrisRR 3y agoTechnically no it doesn't. I had thought that curing did mean fixing the problem, but I just googled and it does indeed also mean relieving of the symptoms. But I think in this case they're right to clarify. I think the low level of common knowledge around gene editing could lead people to believe that this is mutating the sickle cells into healthy cells, which it isn't doing
- WhitneyLand 3y agoIt might clarify how it actually works, but he’s saying it’s not a cure, and if that’s not factually correct that’s not a good thing.
- DoreenMichele 3y agoI read of a guy using a virus to deliver the DNA to his gut to fix his lactose intolerance. That was the first thing I read that made me feel more comfortable with the idea of gene therapy. I'm not readily finding an explanation for how CRISPR works that makes sense to me and the current top comment* indicates this isn't actually a cure. I was hoping to get some idea of how CRISPR and a virus delivery mechanism compare. * https://news.ycombinator.com/item?id=38359048 https://news.ycombinator.com/item?id=38359048
- RockRobotRock 3y agohttps://www.youtube.com/watch?v=J3FcbFqSoQY https://www.youtube.com/watch?v=J3FcbFqSoQY
- mdemonkhan1234 3y ago[flagged]
- codedokode 3y agoWhat do you think about mandatory DNA screening? I.e. analyse DNA of everyone who wants to have children and do not allow it if there are defective genes? This way we could save a lot on research and treating currently incurable diseases (there would be no children with such diseases and no need for treating them).
- superb_dev 3y agoHow is it enforced, and how do we decide which diseases trigger this?
- codedokode 3y agoAs I understand the most difficult to cure and incurable diseases are those that are encoded in DNA (DNA contains errors and invalid sequences which cause the disease). So instead of making multi-billion research and cure that costs millions of dollars, wouldn't it be easier to make everyone check their DNA and warn about presence of invalid sequences causing diseases? So that no more sick children are born and no need to buy pills for millions of dollars. The DNA testing should be mandatory for everyone, but let parents decide for themselves if they want a child with an incurable disease. Maybe we should make them pay extra taxes if they ignore the warning.
- mpweiher 3y agohttps://en.wikipedia.org/wiki/Eugenics https://en.wikipedia.org/wiki/Eugenics
- codedokode 3y agoSo you think parents should not know and should not care whether their children will have an incurable disease? According to Wiki: "Sickle cell disease occurs when a person inherits two abnormal copies of the β-globin gene (HBB) that makes haemoglobin, one from each parent". So basically this disease is encoded in DNA and it can be predicted whether future child will inherit it. Mandatory DNA screening could result in zero people having this disease (and other expensive to treat or incurable diseases). There will be no need to spend large money researching it, and those money can be used for more important non-genetic diseases. Of course, religious people would be against this but we as a society should rely on science, not on blind faith.